explore -WSS

explore

author：leisure time 2025-10-01 22:49:24 - browse：2961

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： What Henrietta Lacks's story taught me about my role as a doctor

hotspot

WSS

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

4 missing after record

Antivenom research: Lessons from HIV applied in search for universal antidote

Alabama IVF ruling threatens families facing fatal genetic disease

Medicare inequities exacerbate Puerto Rico’s health disparities

hotspot

explore

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Why palliative psychiatry is worth discussing

Anesthesiologist group: stop taking Ozempic before surgery

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Severe heat forecast: Where scorching temperatures will persist over the next week

Walensky prepares to leave CDC — and Congress — behind

STAT readers on older presidents, polypills, Medicare, and more

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

entertainment

Medicare inequities exacerbate Puerto Rico’s health disparities

Severe heat forecast: Where scorching temperatures will persist over the next week

How to protect coverage of PrEP

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Ed Silverman on new gene therapies, biosimilars, coffee, and more

6 phony surgeries that take placebo to the extreme

hotspot

hotspot

focus

focus